Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells

First-generation adenovirus can be engineered with powerful promoters to drive expression of therapeutic transgenes. Numerous clinical trials for glioblastoma multiforme using first generation adenoviral vectors have either been performed or are ongoing, including an ongoing, Phase III, multicenter...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Barcia, Carlos, Gerdes, Christian, Xiong, Wei-Dong, Thomas, Clare E., Liu, Chunyan, Kroeger, Kurt M., Castro, Maria G., Lowenstein, Pedro R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2007
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2139984/
https://ncbi.nlm.nih.gov/pubmed/18084640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1740925X07000579
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky